Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 305 entries
View as:

Survival Analysis: TACE vs. Combination Therapy in HCC

Phase: N/A Priority: Normal
NCT ID: NCT06261138 Org: User:
Start: 02/01/19 End: 10/31/23 Due: 10/31/24

Study on Serum Metabolomics of GDM

Phase: N/A Priority: Normal
NCT ID: NCT05881616 Org: User:
Start: 07/18/23 End: 05/31/26 Due: 05/31/27

Investigate the Clinical Responses of Ethosuximide in Patients With Treatment-Resistant Depression.

Phase: N/A Priority: Normal
NCT ID: NCT03887624 Org: User:
Start: 05/21/19 End: 04/01/21 Due: 04/01/22

Sequences of Aerobic and Resistance Exercise and Cardio-metabolic Functions in T2D

Phase: N/A Priority: Normal
NCT ID: NCT06145542 Org: User:
Start: 09/25/23 End: 07/02/24 Due: 07/02/25

Soy Fiber Improves Weight Loss and Lipid Profile

Phase: N/A Priority: Normal
NCT ID: NCT01802840 Org: User:
Start: 03/31/12 End: 07/31/12 Due: 07/31/13

A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Immune Nephritis

Phase: N/A Priority: Normal
NCT ID: NCT05085418 Org: User:
Start: 11/05/21 End: 11/05/24 Due: 11/05/25

ePRO for Adjuvant Therapy of Colorectal Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04069455 Org: User:
Start: 10/01/19 End: 09/30/24 Due: 09/30/25

Precision Nutrition and Food Safety for Dietary Prevention of Chronic Disease Study

Phase: N/A Priority: Normal
NCT ID: NCT05247632 Org: User:
Start: 05/01/18 End: 07/01/28 Due: 07/01/29

Efficacy and Safety of Intravenous YOLT-201 for Transthyretin Amyloidosis Cardiomyopathy

Phase: N/A Priority: Normal
NCT ID: NCT06082050 Org: User:
Start: 11/02/23 End: 02/10/26 Due: 02/10/27

The Efficacy and Safety of Sintilimab Plus Chemotherapy in Surgical Conversion for Patients With Unresectable Stage IIIB-IIIC NSCLC: A Prospective, Single-Arm, Phase II Study

Phase: N/A Priority: Normal
NCT ID: NCT06962189 Org: User:
Start: 05/15/25 End: 12/31/28 Due: 12/31/29

Hepatitis B Virus Reactivation: a Cautionary Event After Liver Transplantation for Patients With Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06114251 Org: User:
Start: 01/01/15 End: 06/01/23 Due: 06/01/24

Second-Line Oxaliplatin and Irinotecan Versus Irinotecan Alone for Gemcitabine and S-1 Refractory Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02558868 Org: User:
Start: 09/01/15 End: 12/31/17 Due: 12/31/18

Breast-Specific Gamma Imaging and Locally Advanced Breast Cancer Undergoing Neoadjuvant Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT02556684 Org: User:
Start: 09/30/15 End: 10/31/20 Due: 10/31/21

Irinotecan Liposome for Resectable Pancreatic Cancer With or Without Addebelizumab

Phase: N/A Priority: Normal
NCT ID: NCT06172036 Org: User:
Start: 01/20/24 End: 01/20/27 Due: 01/20/28

Fish, Polyunsaturated Fatty Acids Intake and Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT03259321 Org: User:
Start: 01/01/89 End: 12/31/12 Due: 12/31/13

Ruxolitinib With Calcineurin Inhibitor and Methotrexate vs. Calcineurin Inhibitor Plus Methotrexate and Mycophenolate Mofetil as Graft Versus Host Disease Prophylaxis for HLA-haploidentical Hematopoietic Stem Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT04838704 Org: User:
Start: 04/01/21 End: 12/01/24 Due: 12/01/25

Effect of Finerenone in IgA Nephropathy

Phase: N/A Priority: Normal
NCT ID: NCT06580288 Org: User:
Start: 10/08/24 End: 10/08/26 Due: 10/08/27

Influence of Intraoperative Blood Salvage and Autotransfusion on Tumor Recurrence After Deceased Donor Liver Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT06307158 Org: User:
Start: 01/01/15 End: 12/31/21 Due: 12/31/22

Psychophysiological Effects of Music

Phase: N/A Priority: Normal
NCT ID: NCT06516666 Org: User:
Start: 04/18/23 End: 06/20/23 Due: 06/20/24

A Phase II Trial to Evaluate the Efficiency and Safety of Serplulimab Plus Chemotherapy as Conversion Therapy in NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT05837052 Org: User:
Start: 05/15/23 End: 12/30/26 Due: 12/30/27

A Clinical Study of CD19/BCMA CAR-T Cells in the Treatment of Refractory POEMS Syndrome, Amyloidosis, Autoimmune Hemolytic Anemia, and Vasculitis

Phase: N/A Priority: Normal
NCT ID: NCT05263817 Org: User:
Start: 10/08/21 End: 10/01/24 Due: 10/01/25

NKG2D CAR-NK Cell Therapy in Patients With Refractory Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05213195 Org: User:
Start: 12/10/21 End: 06/30/25 Due: 06/30/26

Sensory Evaluation of Chinese Specialty Foods

Phase: N/A Priority: Normal
NCT ID: NCT06736834 Org: User:
Start: 12/18/24 End: 12/30/24 Due: 12/30/25

Evaluate the Safety, Efficacy and Pharmacokinetics of ThisCART19A in Patients With MRD+ B-ALL

Phase: N/A Priority: Normal
NCT ID: NCT05350852 Org: User:
Start: 03/18/22 End: 04/30/24 Due: 04/30/25

Neoadjuvant Therapy for Locally Advanced Colon Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04625803 Org: User:
Start: 01/04/21 End: 09/30/23 Due: 09/30/24